Steatohepatitis in children

Bailliere's Best Practice and Research in Clinical Gastroenterology

Volumn 16, Issue 5, 2002, Pages 749-765

  Roberts, Eve A ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

Acanthosis nigricans; Children; Cirrhosis; Hyperinsulinaemia; Insulin resistance; Obesity; Steatohepatitis; Steatosis

Indexed keywords

CHILD; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; FATTY LIVER; HUMAN; HYPERINSULINISM; INSULIN RESISTANCE; OBESITY; PRESCHOOL CHILD; REVIEW; RISK FACTOR; ACANTHOSIS NIGRICANS; ALSTROM SYNDROME; AUTOSOMAL RECESSIVE DISORDER; BARDET BIEDL SYNDROME; BODY MASS; CANCER SURVIVAL; CHILDHOOD CANCER; CHILDHOOD DISEASE; CHRONIC HEPATITIS; CLINICAL FEATURE; CLINICAL TRIAL; COHEN SYNDROME; CYSTIC FIBROSIS; DIET SUPPLEMENTATION; DRUG MEGADOSE; EXERCISE; GENETIC DISORDER; HEALTH SURVEY; HISTOPATHOLOGY; HYPERINSULINEMIA; INCIDENCE; LIFESTYLE; LIPODYSTROPHY; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER FIBROSIS; LIVER TOXICITY; METABOLIC DISORDER; NON INSULIN DEPENDENT DIABETES MELLITUS; NONALCOHOLIC FATTY LIVER; OVARY POLYCYSTIC DISEASE; PRADER WILLI SYNDROME; SYNDROME; TURNER SYNDROME; WEIGHT REDUCTION; WILSON DISEASE; AGE; CHILDHOOD; GENE MUTATION; HEPATITIS; INHERITANCE; LIVER DISEASE; PATHOGENESIS; SEX DIFFERENCE;

CHILD; CHILD, PRESCHOOL; DIAGNOSIS, DIFFERENTIAL; DISEASE PROGRESSION; FATTY LIVER; HUMANS; HYPERINSULINISM; INSULIN RESISTANCE; OBESITY; RISK FACTORS;

ALCOHOL; ALPHA TOCOPHEROL; ASPARAGINASE; BETAINE; METFORMIN; METHOTREXATE; PREDNISONE; RETINOL; URSODEOXYCHOLIC ACID; CORTICOSTEROID; HFE PROTEIN; INSULIN; REACTIVE OXYGEN METABOLITE;

EID: 0036781974     PISSN: 15216918     EISSN: None     Source Type: Journal    
DOI: 10.1053/bega.2002.0331     Document Type: Article

References (144)

1. Adler M Schaffner F Fatty liver hepatitis and cirrhosis in obese patients American Journal of Medicine 67 1979 811-816
2. Ludwig J Viggiano T R McGill D B Ott B J Non-alcoholic steatohepatitis: Mayo Clinic experience with a hitherto unnamed disease Mayo Clinic Proceedings 55 1980 434-438
3. Bacon B R Farahwash M J Lanney C G Neuschwander-Tetri B A Non-alcoholic steatohepatitis: an expanded clinical entity Gastroenterology 107 1994 1103-1109
4. George D K Goldwurm S MacDonald G A et al. Increased hepatic iron concentration in nonalcoholic steatohepatitis is associated with increased fibrosis Gastroenterology 114 1998 311-318
5. Czaja A J Frequency and significance of phenotypes for alpha1-antitrypsin deficiency in type 1 autoimmune hepatitis Digestive Diseases and Sciences 43 1998 1725-1731
6. Brunt E M Nonalcoholic steatohepatitis: definition and pathology Seminars in Liver Diseases 21 2001 3-16
7. Palmer M Schaffner F Effect of weight reduction on hepatic abnormalities in overweight patients Gastroenterology 99 1990 1408-1413
8. Teli M R James O F Burt A D Bennett M K Day C P The natural history of nonalcoholic fatty liver: a follow-up study Hepatology 22 1995 1714-1719
9. Lee R G Nonalcoholic steatohepatitis: a study of 49 patients Human Pathology 20 1989 594-598
10. Wanless I R Lentz J S Fatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with analysis of risk factors Hepatology 12 1990 1106-1110
11. Powell E E Cooksley W GE Hanson R et al. The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years Hepatology 11 1990 74-80
12. Willner I R Waters B Patil S R et al. Ninety patients with nonalcoholic steatohepatitis: insulin resistance, familial tendency, and severity of disease American Journal of Gastroenterology 96 2001 2957-2961
13. Molloy R M Komorowski R Varma R R Recurrent nonalcoholic steatohepatitis and cirrhosis after liver transplantation Liver Transplantation and Surgery 3 1997 177-178
14. Charlton M Kasparova P Weston S et al. Frequency of nonalcoholic steatohepatitis as a cause of advanced liver disease Liver Transplantation 7 2001 608-614
15. Ong J Younossi Z M Reddy V et al. Cryptogenic cirrhosis and posttransplantation nonalcoholic fatty liver disease Liver Transplantation 7 2001 797-801
16. Contos M J Cales W Sterling R K et al. Development of nonalcoholic fatty liver disease after orthotopic liver transplantation for cryptogenic cirrhosis Liver Transplantation 7 2001 363-373
17. Zen Y Katayanagi K Tsuneyama K et al. Hepatocellular carcinoma arising in non-alcoholic steatohepatitis Pathology International 51 2001 127-131
18. Marchesini G Brizi M Morselli-Labate A M et al. Association of nonalcoholic fatty liver disease with insulin resistance American Journal of Medicine 107 1999 450-455
19. Tankurt E Biberoglu S Ellidokuz E et al. Hyperinsulinemia and insulin resistance in non-alcoholic steatohepatitis Journal of Hepatology 31 1999 963
20. Sanyal A J Campbell-Sargent C Mirshahi F et al. Non-alcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities Gastroenterology 120 2001 1183-1192
21. Paradis V Perlemuter G Bonvoust F et al. High glucose and hyperinsulinemia stimulate connective tissue growth factor expression: a potential mechanism involved in progression to fibrosis in nonalcoholic steatohepatitis Hepatology 34 2001 738-744
22. Cortez-Pinto H Camilo M E Baptista A De Oliveira A G De Moura M C Non-alcoholic fatty liver: another feature of the metabolic syndrome? Clinical Nutrition 18 1999 353-358
23. Luyckx F H Lefebvre P J Scheen A J Non-alcoholic steatohepatitis: association with obesity and insulin resistance, and influence of weight loss Diabetes and Metabolism 26 2000 98-106
24. Day C P James OFW Steatohepatitis: a tale of two “hits” Gastroenterology 114 1998 842-845
25. Chitturi S Farrell G C Etiopathogenesis of nonalcoholic steatohepatitis Seminars in Liver Disease 21 2001 27-41
26. Yang S Q Lin H Z Lane M D Clemens M Diehl A M Obesity increases sensitivity to endotoxin liver injury: implications for the pathogenesis of steatohepatitis Proceedings of the National Academy of Science of the USA 94 1997 2557-2562
27. Visser M Bouter L M McQuillan G M Wener M H Harris T B Elevated C-reactive protein levels in overweight and obese adults Journal of the American Medical Association 282 1999 2131-2135
28. Festa A D'Agostino RJr Williams K et al. The relation of body fat mass and distribution to markers of chronic inflammation International Journal of Obesity and Related Metabolic Disorders 25 2001 1407-1415
29. Pannacciulli N Cantatore F P Minenna A et al. C-reactive protein is independently associated with total body fat, central fat, and insulin resistance in adult women International Journal of Obesity and Related Metabolic Disorders 25 2001 1416-1420
30. Visser M Bouter L M McQuillan G M Wener M H Harris T B Low-grade systemic inflammation in overweight children Pediatrics 107 2001 E13
31. Fromenty B Pessayre D Impaired mitochondrial function in microvesicular steatosis. Effects of drugs, ethanol, hormones and cytokines Journal of Hepatology 26 1997 43-53
32. Pessayre D Berson A Fromenty B Mansouri A Mitochondria in steatohepatitis Seminars in Liver Disease 21 2001 57-69
33. Pessayre D Mansouri A Fromenty B Mitochondrial dysfunction in steatohepatitis American Journal of Physiology. Gastrointestinal and Liver Physiology 282 2002 G193-G199
34. Decsi T Molnar D Koletzko B Reduced plasma concentrations of alpha-tocopherol and beta-carotene in obese boys Journal of Pediatrics 130 1997 653-655
35. Strauss R S Comparison of serum concentrations of alpha-tocopherol and beta-carotene in a cross-sectional sample of obese and nonobese children (NHANES III) Journal of Pediatrics 134 1999 160-165
36. Bonkovsky H L Jawaid Q Tortorelli K et al. Non-alcoholic steatohepatitis and iron: increased prevalence of mutations of the HFE gene in non-alcoholic steatohepatitis Journal of Hepatology 31 1999 421-429
37. Moirand R Mendler M H Guillygomarc'h A Brissot P Deugnier Y Non-alcoholic steatohepatitis with iron: part of insulin resistance-associated hepatic iron overload? Journal of Hepatology 33 2000 1024-1026
38. Thaipisuttikul Y Acanthosis nigricans associated with hepatolenticular degeneration Journal of Dermatology 24 1997 395-400
39. Strauss R S Pollack H A Epidemic increase in childhood overweight, 1986-1998 Journal of the American Medical Association 286 2001 2845-2848
40. Power C Lake J K Cole T Measurement and long-term health risks of child and adolescent fatness International Journal of Obesity and Related Metabolic Disorders 21 1997 507-526
41. Kiess W Reich A Muller G et al. Clinical aspects of obesity in childhood and adolescence - diagnosis, treatment and prevention International Journal of Obesity and Related Metabolic Disorders 25 2001 S75-S79 (supplement 1)
42. Tremblay M S Willms J D Secular trends in the body mass index of Canadian children Canadian Medical Association Journal 163 2000 1429-1433
43. Livingstone B Epidemiology of childhood obesity in Europe European Journal of Pediatrics 159 2000 S14-S34 (supplement 1)
44. Livingstone M B Childhood obesity in Europe: a growing concern Public Health Nutrition 4 2001 109-116
45. Fagot-Campagna A Pettitt D J Engelgau M M et al. Type 2 diabetes among North American children and adolescents: an epidemiologic review and a public health perspective Journal of Pediatrics 136 2000 664-672
46. Dietz W H Health consequences of obesity in youth: childhood predictors of adults disease Pediatrics 101 1998 518-525
47. Moran J R Ghishan F K Halter S A Greene H L Steatohepatitis in obese children: a cause of chronic liver dysfunction American Journal of Gastroenterology 78 1983 374-377
48. Kinugasa A Tsunamoto K Furukawa N et al. Fatty liver and its fibrous changes found in simple obesity of children Journal of Pediatric Gastroenterology and Nutrition 3 1984 408-414
49. Vajro P Fontanella A Perna C et al. Persistent hypertransaminasemia resolving after weight reduction in obese children Journal of Pediatrics 125 1994 239-241
50. Baldridge A D Perez-Atayde A R Graeme-Cooke F Higgins L Lavine J E Idiopathic steatohepatitis in childhood: a multicenter retrospective study Journal of Pediatrics 127 1995 700-704
51. Rashid M Roberts E A Non-alcoholic steatohepatitis in children Journal of Pediatric Gastroenterology and Nutrition 30 2000 48-53
52. Manton N D Lipsett J Moore D J et al. Non-alcoholic steatohepatitis in children and adolescents Medical Journal of Australia 173 2000 476-479
53. Kocak N Yuce A Gurakan F Ozen H Obesity: a cause of steatohepatitis in children American Journal of Gastroenterology 95 2000 1099-1100
54. Molleston J P White F Teckman J Fitxgerald J F Obese children with steatohepatitis can develop cirrhosis in childhood American Journal of Gastroenterology 2002
55. Odame I Reilly J J Gibson B E Donaldson M D Patterns of obesity in boys and girls after treatment for acute lymphoblastic leukaemia Archives of Disease in Childhood 71 1994 147-149
56. Mayer E I Reuter M Dopfer R E Ranke M B Energy expenditure, energy intake and prevalence of obesity after therapy for acute lymphoblastic leukaemia during childhood Hormone Research 53 2000 193-199
57. Reilly J J Ventham J C Newell J et al. Risk factors for excess weight gain in children treated for acute lymphoblastic leukaemia International Journal of Obesity and Related Metabolic Disorders 24 2000 1537-1541
58. Reilly J J Blacklock C J Dale E Donaldson M Gibson B E Resting metabolic rate and obesity in childhood acute lymphoblastic leukaemia International Journal of Obesity and Related Metabolic Disorders 20 1996 1130-1132
59. Sklar C A Mertens A C Walter A et al .Changes in body mass index and prevalence of overweight in survivors of childhood acute lymphoblastic leukaemia: role of cranial irradiation Medical and Pediatric Oncology 35 2000 91-95
60. Pagano L De Rosa G Voso M T et al. Prevalence of obesity in young adults with acute lymphoblastic leukaemia International Journal of Clinical and Laboratory Research 24 1994 117-119
61. Van Dongen-Melman J E Hokken-Koelega A C Hahlen K et al. Obesity after successful treatment of acute lymphoblastic leukemia in childhood Pediatric Research 38 1995 86-90
62. Parsons S K Skapek S X Neufeld E J et al. Asparaginase-associated lipid abnormalities in children with acute lymphoblastic leukemia Blood 89 1997 1886-1895
63. Shaw M P Bath L E Duff J Kelnar C J Wallace W H Obesity in leukemia survivors: the familial contribution Pediatric Hematology and Oncology 17 2000 231-237
64. Schell M J Ochs J J Schriock E A Carter M A method of predicting adult height and obesity in long-term survivors of childhood acute lymphoblastic leukemia Journal of Clinical Oncology 10 1992 128-133
65. Reilly J J Weir J McColl J H Gibson B E Prevalence of protein-energy malnutrition at diagnosis in children with acute lymphoblastic leukemia Journal of Pediatric Gastroenterology and Nutrition 29 1999 194-197
66. Talvensaari K K Knip M Lanning P Lanning M Clinical characteristics and factors affecting growth in long-term survivors of cancer Medical and Pediatric Oncology 26 1996 166-172
67. Talvensaari K K Lanning M Tapanainen P Knip M Long-term survivors of childhood cancer have an increased risk of manifesting the metabolic syndrome Journal of Clinical Endocrinology and Metabolism 81 1996 3051-3055
68. Cruz P D Jr. Hud J A Jr. Excess insulin binding to insulin-like growth factor receptors: proposed mechanism for acanthosis nigricans Journal of Investigative Dermatology 98 1992 82S-85S
69. Brockow K Steinkraus V Rinninger F Abeck D Ring J Acanthosis nigricans: a marker for hyperinsulinemia Pediatric Dermatology 12 1995 323-326
70. Stuart C A Gilkison C R Smith M M et al. Acanthosis nigricans as a risk factor for non-insulin dependent diabetes mellitus Clinical Pediatrics 37 1998 73-79
71. Mulchtar Q Cleverly G Voorhees R E McGrath J W Prevalence of acanthosis nigricans and its association with hyperinsulinemia in New Mexico adolescents Journal of Adolescent Health 28 2001 372-376
72. Kahn C R Flier J S Bar R S et al. The syndrome of insulin resistance and acanthosis nigricans: insulin-receptor disorders in man New England Journal of Medicine 294 1976 739-745
73. Yanovski J A Arioglu E When a child can't clean her neck Journal of Pediatrics 138 2001-608
74. Boor R Herwig J Schrezenmeir J Pontz B F Schonberger W Familial insulin resistant diabetes associated with acanthosis nigricans, polycystic ovaries, hypogonadism, pigmentary retinopathy, labyrinthine deafness, and mental retardation American Journal of Medical Genetics 45 1993 649-653
75. Richards G E Cavallo A Meyer W J et al. Obesity, acanthosis nigricans, insulin resistance and hyperandrogenemia: pediatric perspective and natural history Journal of Pediatrics 107 1985 893-897
76. Tominaga K Kurata J H Chen Y K et al. Prevalence of fatty liver in Japanese children and relationship to obesity. An epidemiological ultrasonographic survey Digestive Diseases and Sciences 40 1995 2002-2009
77. Bergomi A Iughetti L Corciulo N et al. Italian multicenter study on liver damage in pediatric obesity International Journal of Obesity and Related Metabolic Disorders 22 1998 S22 (Abstract)
78. Tazawa Y Noguchi H Nishiomiya F Takada G Serum alanine aminotranferase activity in obese children Acta Paediatrica 86 1997 238-241
79. Strauss R S Barlow S E Dietz W H Prevalence of abnormal serum aminotransferase values in overweight and obese adolescents Journal of Pediatrics 136 2000 727-733
80. Green J S Parfrey P S Harnett J D et al. The cardinal manifestations of Bardet-Biedl syndrome, a form of Laurence-Moon-Biedl syndrome New England Journal of Medicine 321 1989 1002-1009
81. Escallon F Traboulsi E I Infante R A family with the Bardet-Biedl syndrome and diabetes mellitus Archives of Ophthalmology 107 1989 855-857
82. Carmi R Elbedour K Stone E M Sheffield V C Phenotypic differences among patients with Bardet-Biedl syndrome linked to three different chromosome loci American Journal of Medical Genetics 59 1995 199-203
83. Woods M O Young T L Parfrey P S et al. Genetic heterogeneity of Bardet-Biedl syndrome in a distinct Canadian population: evidence for a fifth locus Genomics 55 1999 2-9
84. Young T L Woods M O Parfrey P S et al. A fifth locus for Bardet-Biedl syndrome maps to chromosome 2q31 American Journal of Human Genetics 64 1999 900-904
85. Sheffield V C Nishimura D Stone E M The molecular genetics of Bardet-Biedl syndrome Current Opinion in Genetics and Development 11 2001 317-321
86. Katsanis N Lupski J R Beales P L Exploring the molecular basis of Bardet-Biedl syndrome Human Molecular Genetics 10 2001 2293-2299
87. Hamacher M Pippirs U Kohler A Muller H W Bosse F Plasmolipin: genomic structure, chromosomal localization, protein expression pattern, and putative association with Bardet-Biedl syndrome Mammalian Genome 12 2001 933-937
88. Mykytyn K Braun T Carmi R et al. Identification of the gene that, when mutated, causes the human obesity syndrome BBS4 Nature Genetics 28 2001 188-191
89. Pagon R A Haas J E Bunt A H Rodaway K A Hepatic involvement in the Bardet-Biedl syndrome American Journal of Medical Genetics 13 1982 373-381
90. Michaud J L Heon E Guilbert F et al. Natural history of Alström syndrome in early childhood: onset with dilated cardiomyopathy Journal of Pediatrics 128 1996 225-229
91. Russell-Eggitt I M Clayton P T Coffey R et al. Alström syndrome. Report of 22 cases and literature review Ophthalmology 105 1998 1274-1280
92. Zumsteg U Muller P Y Miserez A R Alström syndrome: confirmation of linkage to chromosome 2p12-13 and phenotypic heterogeneity in three affected sibs Journal of Medical Genetics 37 2000 E8
93. Sebag J Albert D M Craft J L The Alström syndrome: ophthalmic histopathology and retinal ultrastructure British Journal of Ophthalmology 68 1984 494-501
94. Connolly M B Jan J E Couch R M et al. Hepatic dysfunction in Alström disease American Journal of Medical Genetics 40 1991 421-424
95. Awazu M Tanaka T Sato S et al. Hepatic dysfunction in two sibs with Alström syndrome: case report and review of the literature American Journal of Medical Genetics 69 1997 13-16
96. Awazu M Tanaka T Yamazaki K et al. A 27-year-old woman with Alström syndrome who had liver cirrhosis Keio Journal of Medicine 44 1995 67-73
97. Chou P I Chen C H Chen J T et al. Alström syndrome with subclinical insulin-resistant diabetes and hepatic dysfunction: a family report Journal of Pediatric Ophthalmology and Strabismus 37 2000 179-182
98. Chang K W Hou J W Lin S J Kong M S Alström syndrome with hepatic dysfunction: report of one case Acta Paediatrica Taiwanica 41 2000 270-272
99. Marshall J D Ludman M D Shea S E et al. Genealogy, natural history, and phenotype of Alström syndrome in a large Acadian kindred and three additional families American Journal of Medical Genetics 73 1997 150-161
100. Chen B H Chiou S S Tsai R K Lin Y F Wu J R Acute lymphoblastic leukemia in one of two siblings with Alström syndrome Journal of the Formosan Medical Association 99 2000 792-795
101. Hung Y J Jeng C Pei D Chou P I Wu D A Alström syndrome in two siblings Journal of the Formosan Medical Association 100 2001 45-49
102. Quiros-Tejeira R E Vargas J Ament M E Early-onset liver disease complicated with acute liver failure in Alström syndrome American Journal of Medical Genetics 101 2001 9-11
103. Hauser C Rojas C Roth A Schmied E Saurat J H A patient with features of both Bardet-Biedl and Alström syndromes European Journal of Paediatrics 149 1990 783-785
104. Kivitie-Kallio S Norio R Cohen syndrome: essential features, natural history, and heterogeneity American Journal of Medical Genetics 102 2001 125-135
105. Kumandas S Gumus H Kurtoglu S Elmas B Kontas O Cohen syndrome with acanthosis nigricans and insulin resistance Journal of Pediatric Endocrinology and Metabolism 14 2001 807-810
106. Lewy V D Danadian K Witchel S F Arslanian S Early metabolic abnormalities in adolescent girls with polycystic ovarian syndrome Journal of Pediatrics 138 2001 38-44
107. Conway G S Jacobs H S Acanthosis nigricans in obese women with the polycystic ovary syndrome: disease spectrum not distinct entity Postgraduate Medical Journal 66 1990 536-538
108. Dunaif A Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis Endocrine Reviews 18 1997 774-800
109. Parsanezhad M E Alborzi S Zarei A Dehbashi S Omrani G Insulin resistance in clomiphene responders and non-responders with polycystic ovarian disease and therapeutic effects of metformin International Journal of Gynaecology and Obstetrics 75 2001 43-50
110. Nardo L G Rai R Metformin therapy in the management of polycystic ovary syndrome: endocrine, metabolic and reproductive effects Gynecological Endocrinology 15 2001 373-380
111. De Conciliis B Passannanti G Romano L Santarpia R Effects of metformin on the insulin resistance and on ovarian steroidogenesis in women with polycystic ovary syndrome Minerva Ginecologica 53 2001 239-250
112. Batukan C Baysal B Metformin improves ovulation and pregnancy rates in patients with polycystic ovary syndrome Archives of Gynecology and Obstetrics 265 2001 124-127
113. Salerno M DiMaio S Gasparini N et al. Liver abnormalities in Turner syndrome European Journal of Pediatrics 158 1999 618-623
114. Sato H Miyamoto S Sasaki N Liver abnormality in Turner syndrome European Journal of Pediatrics 160 2001 59
115. Gunay-Aygun M Cassidy S B Nicholls R D Prader-Willi and other syndromes associated with obesity and mental retardation Behavior Genetics 27 1997 307-324
116. Chan N N Feher M D Bridges N A Metformin therapy for diabetes in Prader-Willi syndrome Journal of the Royal Society of Medicine 91 1998 598
117. Yamakita T Ishii T Mori T et al. Troglitazone ameliorates insulin resistance in a diabetic patient with Prader-Willi syndrome Diabetes Research and Clinical Practice 42 1998 205-208
118. Reitman M L Arioglu E Gavrilova O Taylor S I Lipoatrophy revisited Trends in Endocrinology and Metabolism 11 2000 410-416
119. Powell E E Searle J Mortimer R Steatohepatitis associated with limb lipodystrophy Gastroenterology 97 1989 1022-1024
120. Cauble M S Gilroy R Sorrell M F et al. Lipoatrophic diabetes and end-stage liver disease secondary to nonalcoholic steatohepatitis with recurrence after liver transplantation Transplantation 71 2001 892-895
121. Magre J Delepine M Khallouf E et al. Identification of the gene altered in Berardinelli-Seip congenital lipodystrophy on chromosome 11q13 Nature Genetics 28 2001 365-370
122. De Sandre-Giovannoli A Chaouch M Kozlov S et al. Homozygous defects in LMNA, encoding lamin A/C nuclear-envelope proteins, cause autosomal recessive axonal neuropathy in human (Charcot-Marie-Tooth disorder type 2) and mouse American Journal of Human Genetics 70 2002 726-736
123. Shackleton S Lloyd D J Jackson S N et al. LMNA, encoding lamin A/C, is mutated in partial lipodystrophy Nature Genetics 24 2000 153-156
124. Agarwal A K Garg A A novel heterozygous mutation in peroxisome proliferator-activated receptor-gamma gene in a patient with familial partial lipodystrophy Journal of Clinical Endocrinology and Metabolism 87 2002 408-411
125. Colombo C Crosignani A Battezzati P M Liver involvement in cystic fibrosis Journal of Hepatology 31 1999 946-954
126. Lindblad A Glaumann H Strandvik B Natural history of liver disease in cystic fibrosis Hepatology 30 1999 1151-1158
127. Roy C C Weber A M Morin C L et al. Abnormal biliary lipid composition in cystic fibrosis: effect of pancreatic enzymes New England Journal of Medicine 297 1977 1301-1305
128. Lepage G Champagne J Ronco N et al. Supplementation with carotenoids corrects increased lipid peroxidation in children with cystic fibrosis American Journal of Clinical Nutrition 64 1996 87-93
129. Lepage G Levy E Ronco N et al. Direct esterification of plasma fatty acids for the diagnosis of essential fatty acid deficiency in cystic fibrosis Journal of Lipid Research 30 1989 1483-1490
130. Lepage G Paradis K Lacaille F et al. Ursodeoxycholic acid improves the hepatic metabolism of essential fatty acids and retinol in children with cystic fibrosis Journal of Pediatrics 130 1997 52-58
131. Treem W R Stanley C A Massive hepatomegaly, steatosis, and secondary plasma carnitine deficiency in an infant with cystic fibrosis Pediatrics 83 1989 993-997
132. Tazawa Y Noguchi H Mishiomiya F Takada G Effect of weight reduction on serum transaminase activities in children with simple obesity Journal of Pediatrics 128 1996 587-588
133. Vajro P Franzese A Valerio G Iannucci M P Aragione N Lack of efficacy of ursodeoxycholic acid for the treatment of liver abnormalities in obese children Journal of Pediatrics 136 2000 739-743
134. Lavine J E Vitamin E treatment of nonalcoholic steatohepatitis in children: a pilot study Journal of Pediatrics 136 2000 734-738
135. Angulo P Lindor K D Treatment of nonalcoholic fatty liver: present and emerging therapies Seminars in Liver Disease 21 2001 81-88
136. Laurin J Lindor K D Crippin J S et al. Ursodeoxycholic acid or clofibrate in the treatment of non-alcohol-induced steatohepatitis: a pilot study Hepatology 23 1996 1464-1467
137. Marchesini G Brizi M Bianchi G et al. Metformin in non-alcoholic steatohepatitis Lancet 358 2001 893-894
138. Glueck C J Fontaine R N Wang P et al. Metformin reduces weight, centripetal obesity, insulin, leptin, and low-density lipoprotein cholesterol in nondiabetic, morbidly obese subjects with body mass index greater than 30 Metabolism 50 2001 856-861
139. Abdelmalek M F Angulo P Jorgensen R A Sylvestre P B Lindor K D Betaine, a promising new agent for patients with nonalcoholic steatohepatitis: results of a pilot study American Journal of Gastroenterology 96 2001 2711-2717
140. Neuschwander-Tetri B A Betaine: an old therapy for a new scourge American Journal of Gastroenterology 96 2001 2534-2536
141. Spieth L E Harnish J D Lenders C M et al. A low-glycemic index diet in the treatment of pediatric obesity Archives of Pediatrics and Adolescent Medicine 154 2000 947-951
142. Goldfield G S Epstein L H Kilanowski C K Paluch R A Kogut-Bossler B Cost-effectiveness of group and mixed family-based treatment for childhood obesity International Journal of Obesity and Related Metabolic Disorders 25 2001 1843-1849
143. Velazquez E M Mendoza S Hamer T Sosa F Glueck C J Metformin therapy in polycystic ovary syndrome reduces hyperinsulinemia, insulin resistance, hyperandrogenemia, and systolic blood pressure, while facilitating normal menses and pregnancy Metabolism 43 1994 647-654
144. Velazquez E M Mendoza S G Wang P Glueck C J Metformin therapy is associated with a decrease in plasma plasminogen activator inhibitor-1, lipoprotein(a), and immunoreactive insulin levels in patients with the polycystic ovary syndrome Metabolism 46 1997 454-457